DaVita CEO Kent Thiry and an aerial shot of 1237 East Main Street
A new dialysis clinic in Alhambra has sold for $15 million, showing the strength of a niche market catering to the chronically ill.
The seller was an Alabama-based developer named B2 Partners (pronounced “B-squared”), which bought the block-through site at 1237 E. Main Street in 2016 for $5.5 million.
B2 redeveloped the 14,125-square-foot property last March and signed up dialysis giant DaVita, Inc. to a 15-year triple-net lease that started in June. The clinic sits on a 1.2-acre lot.
Dialysis clinics promise a good income stream for landlords who can afford to build out a specialized medical space and deal with the red tape of a regulated industry.
“We do a lot of dialysis in Southern California,” said Grady Liu, a broker with MacroReal Commercial, who represented the buyer, a local family acting through an entity named Jinbo Holdings LLC. “It’s a more stable opportunity than for office, retail, or drug stores.”
That’s partly because competition in the field is weak, Liu added. DaVita, a Fortune 500 company that runs thousands of clinics around the country, has only one real competitor: Fresenius, a German-held corporation that, coincidentally, runs a nearby clinic at 2300 W. Valley Boulevard.
And people will never stop getting older or sicker. A marketing package for the Alhambra property prepared by Preserve West Capital touted the area’s aging population, saying its 11.3-percent diabetes rate exceeds the national average. Lennar Corp. is also redeveloping a senior center on Marengo Avenue.
Rental income at the Alhambra property starts at $791,000 annually, with built-in increases every five years, according to the brochure.
Putnam Daily and Michael Maffia of Preserve West Capital marketed the property for B2.
B2 could not be reached for comment.
Powered by WPeMatico